Previous close | 58.45 |
Open | 58.40 |
Bid | 58.51 x 1400 |
Ask | 58.99 x 800 |
Day's range | 58.29 - 58.69 |
52-week range | 31.80 - 60.20 |
Volume | |
Avg. volume | 1,724,037 |
Market cap | 10.62B |
Beta (5Y monthly) | 1.16 |
PE ratio (TTM) | N/A |
EPS (TTM) | -6.48 |
Earnings date | 27 Aug 2024 - 02 Sept 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 58.30 |
Key Insights Catalent's estimated fair value is US$76.85 based on 2 Stage Free Cash Flow to Equity Catalent is...
UTHR vs. CTLT: Which Stock Is the Better Value Option?
Catalent's (CTLT) latest capability expansion is expected to boost its business in the global clinical trials space in its Clinical Development & Supply network.